Sharepoint Solutions
PRODUCTS
-
With over 130 in-life gene therapy studies completed, Altasciences is a leading expert in gene therapy research, with integrated preclinical and bioanalytical capabilities.
-
Our goal is to help your business succeed by working with you to streamline the FDA regulatory process. ProPharma’s team of science- based regulatory consultants commands an unparalleled breadth and depth of knowledge pertaining to FDA’s regulatory framework and can work with you to accomplish your business objectives.
-
At Ideagen, we're committed to empowering seamless collaboration and enhancing your document review process. Through strategic alliances with leading technology providers across the life science industry, we offer integrations that amplify the efficiency and effectiveness of your workflows.
-
We provide science-first solutions for challenging molecules, specializing in particle engineering, bioavailability, and GMP manufacturing across Bend, OR; Clearwater, FL; and Gainesville, GA.
-
“Services” and “support.” What do those words mean in the life science manufacturing industry? The truth is, they’re quite subjective—and relative to each company. Here’s how we define services and support at Cytiva.
WHITE PAPERS AND CASE STUDIES
-
Regulatory Considerations For Excipients Used In Lipid Nanoparticles
Review the regulatory classification of LNPs, liposomes, and novel excipients as well as specific requirements outlined in regulatory guidance documents and strategies to navigate emerging challenges.
-
An Introduction To Passive Radar Systems
Dive into the concept and operating principles of passive radar systems, review the basics of bistatic radars, and introduce the concept of emitters of opportunity (EoO) and their ideal qualities.
-
Mobile Application Considerations For Clinical Trials And Beyond
Delve into fundamental definitions, navigate through the regulatory landscape, and examine common applications of mobile apps in research.
-
Rescuing A Global Full-Service Phase III Trial For A Late-Stage Oncology Biotech
This case underscores the expertise employed in a comprehensive strategy and set of services that were used to salvage a Phase III clinical trial for ovarian cancer and ensure its timely completion.
-
Case Study: Recruiting Pediatric Ultra-Rare Disease Patients
Explore how Rezolute was able to overcome challenges while recruiting pediatric patients for a Congenital Hyperinsulinism (HI) clinical trial using a streamlined, single-source tool.
-
Earning RMAT Designation - What Developers Need To Know
Explore a high-level overview of the Regenerative Medicine Advanced Therapy designation and how to ensure success and accelerate advanced therapy products toward commercialization.
-
De-Risking Preclinical Candidates With Predictive Immunotoxicology
From target engagement and mechanism of action to efficacy and prediction of adverse immune reactions, immunology assays deliver data that reduce your risk of failing later.
-
Improving Patient Health and Safety: Quality and Analytical Scientist
Explore how an analytical scientist enhanced quality and compliance for a pharmaceutical company by managing complex analytical testing and vendor interactions.
-
CRO Leverages Partnership With Integrated Central IBC To Initiate Sites
Discover how a CRO was able to reduce study startup timelines and deliver trial results to the sponsor quicker than expected.
-
Aseptic Filling Solution Enhances Sterility Assurance for Pharma Manufacturer
Emergent BioSolutions upgraded its Winnipeg site with the Cytiva SA25 aseptic filling workcell to improve sterility assurance, product flexibility, and regulatory compliance for CGT manufacturing.
-
Are You Leveraging All Of Your Clinical Data?
To develop and execute a successful clinical strategy, trial sponsors must be able to rapidly acquire detailed data insights. Learn how you can better utilize your trial data and achieve greater insights.
-
Supporting A Company In Manufacturing The RSM For Treating A Rare Tumour
A clinical-stage oncology company needed a partner to manufacture the RSM. Examine how an optimized RSM manufacturing process helped deliver safe, effective treatment on an accelerated timeline.
NEWS
-
Biden-Harris Administration Announces Over $124M For Tennessee Drinking Water, Wastewater And Stormwater Infrastructure Upgrades As Part Of President Biden's Investing In America Agenda2/23/2024
The U.S. Environmental Protection Agency (EPA) announced over $124M from President Biden’s Investing in America agenda for Tennessee drinking water and clean water infrastructure upgrades.
-
WRF Seeks Pre-Proposals For High-Priority Utility Research2/6/2025
The Water Research Foundation (WRF) is now accepting pre-proposals for its matching research program, the Tailored Collaboration Program.
-
Rapeseed Protein For Vegan Burger Patties And Nutritious Chicken Feed8/13/2025
Food products containing proteins from plants, fungi or algae are becoming increasingly popular. Researchers at the Fraunhofer Center for Chemical-Biotechnological Processes CBP in Leuna, Germany, have now shown that previously rarely used rapeseed proteins are also a valuable source of protein alternatives: using the EthaNa process, they extract not only high-quality rapeseed oil from rapeseed but also a protein-rich rapeseed kernel concentrate, which can be processed for instance into burger patties and pasta or used as a nutritious feed in poultry fattening.
-
EPA Announces $89M Loan To Enhance Wastewater Management In King County12/18/2024
Today, the U.S. Environmental Protection Agency announced an $89M loan to King County, Washington, to help upgrade several wastewater treatment systems. Provided by the EPA’s Water Infrastructure Finance and Innovation Act (WIFIA) loan program, this funding will support projects that improve the reliability of reclaimed water available for use and enhance the system’s resiliency to future seismic events.
-
Biden-Harris Administration Announces Over $125M For Georgia Drinking Water, Wastewater And Stormwater Infrastructure Upgrades As Part Of President Biden's Investing In America Agenda2/23/2024
The U.S. Environmental Protection Agency (EPA) announced over $125M from President Biden’s Investing in America agenda for Georgia drinking water and clean water infrastructure upgrades.